Pay with Crypto and get 10% off your order!
LabCorp

Gynecologic Pap Test-Age-based Guideline for Cervical Cancer (Aptima®) *

$80.00
7011
193065
Only 100 units of this product remain
Phlebotomy (IV Blood Draw)

Diagnose primary or metastatic neoplasm. High-risk HPV is used for types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, without differentiation of the individual type. When the age guideline includes possible genotyping, the residual specimen will be tested individually for high-risk HPV genotypes 16 and 18,45 if the Pap evaluation is within normal limits and the initial HPV test is positive. This information, together with the physician's assessment of cytology history, other risk factors, and professional guidelines, may be used to guide patient management. The results of this test are not intended to prevent women from proceeding to colposcopy.

Failure to obtain adequate ectocervical, endocervical, or vaginal cell population is suboptimal for evaluation. Excessive use of lubricating jelly on the vaginal speculum will interfere with cytologic examination and may lead to unsatisfactory Pap results. The use of the liquid-based cytology specimen for multiple tests may limit the volume available for Pap reprocessing or HPV testing. A negative result does not exclude the possibility of an HPV infection, since very low levels of infection or sampling error may produce a false-negative result. This test detects only the 14 most common high-risk HPV types. Reflex testing for genotypes 16 and 18,45 may be indicated based on patient age and other test results.

1. American College of Obstetrics and Gynecologists. Screening for Cervical Cancer. ACOG Practice Bulletin N° 131, November 2012. Obstet Gynecol. 2012 Nov; 120(5):1222-1238.
 
2. American College of Obstetrics and Gynecologists. Primary and Preventive Care: Periodic Assessments. ACOG Committee Opinion N° 483, April 2011. Obstet Gynecol. 2011 Apr; 117(4):1008-1015.

You might also be interested in